High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

BACKGROUND: Patients with schizophrenia have an increased prevalence of metabolic disturbances compared with the general population. However, the mechanisms underlying the metabolic side effects of antipsychotics are unknown. The aim of the present study was to compare the levels of high-density lip...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Psychiatry
Egile Nagusiak: Ono, Shin, Sugai, Takuro, Suzuki, Yutaro, Yamazaki, Manabu, Shimoda, Kazutaka, Mori, Takao, Ozeki, Yuji, Matsuda, Hiroshi, Sugawara, Norio, Yasui-Furukori, Norio, Okamoto, Kurefu, Sagae, Toyoaki, Someya, Toshiyuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992846/
https://ncbi.nlm.nih.gov/pubmed/29879941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-018-1764-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak